Medicare Overpaid Millions for Organs Not Used in Covered Transplants
An HHS Office of Inspector General report estimates that Medicare paid about $380 million over six years for organs that were not transplanted into Medicare enrollees, due to conflicting federal rules. Of 180 sampled organs, 55 were not used in Medicare-covered transplants, resulting in nearly $2.85 million in reimbursements. The audit found that some organs were used in non-covered transplants or not used at all.
The OIG examined 180 organs across 12 transplant centers, representing $12.3 million in reimbursements. Of these, 125 went to Medicare-covered transplants, while 43 went to non-covered procedures and 12 were never used.
The discrepancy stems from CMS guidance that counts organs transferred to other procurement organizations as Medicare-usable, conflicting with the Social Security Act's ban on paying for non-Medicare patients' services. Additionally, two centers lacked documentation for five organs, leading to $154,210 in improper payments. Medicare disbursed over $3 billion for roughly 39,000 organs in 2023 alone.
This audit could affect Medicare's financial sustainability, as recovering nearly $400 million may free up funds for other beneficiary services. Transplant centers might face stricter documentation requirements and potential repayment obligations, which could alter their operational practices. Patients on transplant waiting lists may see changes in organ allocation efficiency if centers become more cautious about accepting organs that might not be used for Medicare enrollees, potentially impacting access to life-saving procedures.